[MiR-192 confers cisplatin resistance by targeting Bim in lung cancer].
Zhang F, Li Y, Wu H, Qi K, You J, Li X, Zu L, Pan Z, Wang Y, Li Y, Li Y, Wang M, Shen W, Zhou Q.
Zhang F, et al. Among authors: you j.
Zhongguo Fei Ai Za Zhi. 2014 May;17(5):384-90. doi: 10.3779/j.issn.1009-3419.2014.05.04.
Zhongguo Fei Ai Za Zhi. 2014.
PMID: 24854555
Free PMC article.
Chinese.